These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33925558)

  • 1. The Real Need for Regenerative Medicine in the Future of Congenital Heart Disease Treatment.
    Matsuzaki Y; Wiet MG; Boe BA; Shinoka T
    Biomedicines; 2021 Apr; 9(5):. PubMed ID: 33925558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular tissue engineering: From basic science to clinical application.
    Fioretta ES; von Boehmer L; Motta SE; Lintas V; Hoerstrup SP; Emmert MY
    Exp Gerontol; 2019 Mar; 117():1-12. PubMed ID: 29604404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation and Assessment of Functional Biomaterial Scaffolds for Applications in Cardiovascular Tissue Engineering and Regenerative Medicine.
    Hinderer S; Brauchle E; Schenke-Layland K
    Adv Healthc Mater; 2015 Nov; 4(16):2326-41. PubMed ID: 25778713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Off-the-shelf tissue engineered heart valves for in situ regeneration: current state, challenges and future directions.
    Motta SE; Lintas V; Fioretta ES; Hoerstrup SP; Emmert MY
    Expert Rev Med Devices; 2018 Jan; 15(1):35-45. PubMed ID: 29257706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biofabrication of small diameter tissue-engineered vascular grafts.
    Weekes A; Bartnikowski N; Pinto N; Jenkins J; Meinert C; Klein TJ
    Acta Biomater; 2022 Jan; 138():92-111. PubMed ID: 34781026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meeting the need for regenerative therapies: translation-focused analysis of U.S. regenerative medicine opportunities in cardiovascular and peripheral vascular medicine using detailed incidence data.
    Tillman B; Hardin-Young J; Shannon W; Russell AJ; Parenteau NL
    Tissue Eng Part B Rev; 2013 Apr; 19(2):99-115. PubMed ID: 23031078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Tissue Engineering and Regeneration: A Plead for Further Knowledge Convergence.
    Bouten CVC; Cheng C; Vermue IM; Gawlitta D; Passier R
    Tissue Eng Part A; 2022 Jun; 28(11-12):525-541. PubMed ID: 35382591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular tissue engineering: where we come from and where are we now?
    Smit FE; Dohmen PM
    Med Sci Monit Basic Res; 2015 Jan; 21():1-3. PubMed ID: 25623227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue engineering: Relevance to neonatal congenital heart disease.
    Blum KM; Mirhaidari GJM; Breuer CK
    Semin Fetal Neonatal Med; 2022 Feb; 27(1):101225. PubMed ID: 33674254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decellularized tissue-engineered heart valves calcification: what do animal and clinical studies tell us?
    Badria AF; Koutsoukos PG; Mavrilas D
    J Mater Sci Mater Med; 2020 Dec; 31(12):132. PubMed ID: 33278023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heart valve and myocardial tissue engineering].
    Cebotari S; Tudorache I; Schilling T; Haverich A
    Herz; 2010 Aug; 35(5):334-41. PubMed ID: 20631970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue Engineered Materials in Cardiovascular Surgery: The Surgeon's Perspective.
    Durko AP; Yacoub MH; Kluin J
    Front Cardiovasc Med; 2020; 7():55. PubMed ID: 32351975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silk biomaterials for vascular tissue engineering applications.
    Gupta P; Mandal BB
    Acta Biomater; 2021 Oct; 134():79-106. PubMed ID: 34384912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory and regenerative processes in bioresorbable synthetic pulmonary valves up to two years in sheep-Spatiotemporal insights augmented by Raman microspectroscopy.
    De Kort BJ; Marzi J; Brauchle EM; Lichauco AM; Bauer HS; Serrero A; Dekker S; Cox MAJ; Schoen FJ; Schenke-Layland K; Bouten CVC; Smits AIPM
    Acta Biomater; 2021 Nov; 135():243-259. PubMed ID: 34509697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creation of viable pulmonary artery autografts through tissue engineering.
    Shinoka T; Shum-Tim D; Ma PX; Tanel RE; Isogai N; Langer R; Vacanti JP; Mayer JE
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):536-45; discussion 545-6. PubMed ID: 9535439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Porcine Umbilical Cord Perivascular Cells for Preclinical Testing of Tissue-Engineered Heart Valves.
    Latifi N; Lecce M; Simmons CA
    Tissue Eng Part C Methods; 2021 Jan; 27(1):35-46. PubMed ID: 33349127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current status and future trends of reconstructing a vascularized tissue-engineered trachea.
    Shen Z; Xia T; Zhao J; Pan S
    Connect Tissue Res; 2023 Sep; 64(5):428-444. PubMed ID: 37171223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current Status of Tissue Engineering Heart Valve.
    Shinoka T; Miyachi H
    World J Pediatr Congenit Heart Surg; 2016 Nov; 7(6):677-684. PubMed ID: 27834758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells.
    Shin'oka T; Matsumura G; Hibino N; Naito Y; Watanabe M; Konuma T; Sakamoto T; Nagatsu M; Kurosawa H
    J Thorac Cardiovasc Surg; 2005 Jun; 129(6):1330-8. PubMed ID: 15942574
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.